IMS HEALTH (RX)

IMS Health Up 54.3% Since SmarTrend's Buy Recommendation 11/20/2009 13:34:36 Nov 20, 2009 (SmarTrend(R) Spotlight via COMTEX News Network) -- SmarTrend, our proprietary pattern recognition system, called an Uptrend for IMS Health (NYSE:RX) on August 24, 2009 at $13.88. RX, ECL, PNK, CBB, PWE and EQR Receives Analytical Coverage from WallStSense.com 11/17/2009 06:57:21 NEW DELHI, INDIA, Nov 17, 2009 (MARKETWIRE via COMTEX News Network) -- Wallstsense.com is an online community with a dedicated team of analysts who are providing free in-depth research on North... Par Pharmaceutical granted final approval to market generic Ultram ER 11/17/2009 04:15:52 Nov 17, 2009 (M2 EQUITYBITES via COMTEX News Network) -- Generic drugs company Par Pharmaceutical Companies Inc (NYSE:PRX) declared on Monday the receipt of final approval from the US Food and Drug... IMS Health to Release Oncology Quantifier in January 2010 11/17/2009 00:20:19 Nov 17, 2009 (Close-Up Media via COMTEX News Network) -- IMS Health, a provider of market intelligence to the pharmaceutical and healthcare industries, announced the upcoming launch of IMS Oncology... Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER 11/16/2009 08:00:00 WOODCLIFF LAKE, N.J., Nov 16, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has received final approval from the U.S.... More News